Prevention of chemotherapy‐induced vomiting in children receiving multiple‐day cisplatin chemotherapy: A hospital‐based, retrospective cohort study

Background Optimal prevention of chemotherapy‐induced vomiting (CIV) has not been established for patients receiving cisplatin in divided doses. The aim of this study was to describe the incidence and risk factors of CIV in children who received multiple‐day cisplatin chemotherapy. Procedure A total...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Pediatric blood & cancer 2017-09, Vol.64 (9), p.n/a
Hauptverfasser:	Kishimoto, Kenji, Kawasaki, Keiichiro, Saito, Atsuro, Kozaki, Aiko, Ishida, Toshiaki, Hasegawa, Daiichiro, Kosaka, Yoshiyuki
Format:	Artikel
Sprache:	eng
Schlagworte:	Adolescent antiemetic Antiemetics Antiemetics - therapeutic use Antineoplastic Agents - adverse effects Brain cancer Chemotherapy Child Child, Preschool Children Cisplatin Cisplatin - adverse effects Cohort analysis Cohort Studies Dexamethasone Female Hematology Humans Incidence Infant Infant, Newborn Male Neoplasms - drug therapy Neurokinin-1 Receptor Antagonists - therapeutic use Oncology Pediatrics Prophylaxis Radiation Radiation therapy Retrospective Studies Risk Factors Vomiting Vomiting - chemically induced Vomiting - epidemiology Vomiting - prevention & control Young Adult
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!